Chromosome 11 houses a mutation in gene HRAS, LRRC56 (HRas proto-oncogene, GTPase| leucine rich repeat containing 56). Classify its clinical impact — is it pathogenic or benign, and what disease does it lead to if any?
Pathogenic; Cardiovascular phenotype